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investigated 53 patients (2006) investigated 53 patients who were rechallenged with clozapine who were rechallenged with clozapine following leucopenia or neutropenia during following leucopenia or neutropenia during previous therapy and found that 33 did not previous therapy and found that 33 did not experience a second episode of blood dysexperience a second episode of blood dyscrasia and were able to continue drug treatcrasia and were able to continue drug treatment. This result is of considerable clinical ment. This result is of considerable clinical relevance because it suggests that some relevance because it suggests that some patients with leucopenia or neutropenia patients with leucopenia or neutropenia may unnecessarily be denied effective may unnecessarily be denied effective clozapine treatment. clozapine treatment.
We agree that there may be two types We agree that there may be two types of clozapine-associated neutropenia: an of clozapine-associated neutropenia: an early sign of incipient agranulocytosis and early sign of incipient agranulocytosis and a more common transient and harmless a more common transient and harmless phenomenon, not necessitating the disconphenomenon, not necessitating the discontinuation of drug treatment. Transient tinuation of drug treatment. Transient neutropenia (defined as a return of the neutropenia (defined as a return of the neutrophil count to normal values without neutrophil count to normal values without changing the clozapine dosage) was found changing the clozapine dosage) was found in 22% of 68 patients treated with clozain 22% of 68 patients treated with clozapine for the first time (Hummer pine for the first time (Hummer et al et al, , 1994) . Neutropenia of short duration (2-5 1994) . Neutropenia of short duration (2-5 days) and weekly benign variations of the days) and weekly benign variations of the neutrophil count have been reported. neutrophil count have been reported. Marked circadian variations in the number Marked circadian variations in the number of circulating neutrophils (morning pseudoof circulating neutrophils (morning pseudoneutropenia) have also been described in neutropenia) have also been described in several clozapine-treated patients (Ahokas several clozapine-treated patients (Ahokas & Elonen, 1999; Esposito & Elonen, 1999; Esposito et al et al, 2004) . , 2004). The actual issue might therefore not be The actual issue might therefore not be which patients could be rechallenged with which patients could be rechallenged with clozapine following drug-associated clozapine following drug-associated neutropenia but which could be maintained neutropenia but which could be maintained on clozapine despite this side-effect. on clozapine despite this side-effect. Laboratory screening tests, including the Laboratory screening tests, including the use of a hydrocortisone test, are being use of a hydrocortisone test, are being devised to determine whether clozapinedevised to determine whether clozapineassociated neutropenia is transient or associated neutropenia is transient or malignant (Murry & Laurent, 2001 ). malignant (Murry & Laurent, 2001) . Until these tests become available for Until these tests become available for routine use, it is necessary to increase the routine use, it is necessary to increase the frequency with which white blood cell frequency with which white blood cell counts are determined. As first suggested counts are determined. As first suggested by Ahokas & Elonen (1999) , when the by Ahokas & Elonen (1999) , when the absolute neutrophil count is below the absolute neutrophil count is below the normal range in the morning, the test normal range in the morning, the test should be repeated in the afternoon of the should be repeated in the afternoon of the same day before a decision to stop same day before a decision to stop clozapine treatment is made. This might clozapine treatment is made. This might be the basis for further clarification of the be the basis for further clarification of the significance of transient neutropenia. significance of transient neutropenia.
Authors' reply:
Authors' reply: We agree that attempts
We agree that attempts should be made to continue patients on should be made to continue patients on clozapine if at all possible in order to give clozapine if at all possible in order to give them an adequate trial of the drug. The them an adequate trial of the drug. The Clozaril Patient Monitoring Service Clozaril Patient Monitoring Service (CPMS) routinely advises that samples (CPMS) routinely advises that samples should not be taken first thing in the mornshould not be taken first thing in the morning for patients with borderline white cell/ ing for patients with borderline white cell/ neutrophil counts to avoid the problem of neutrophil counts to avoid the problem of morning pseudoneutropenia. Taking sammorning pseudoneutropenia. Taking samples after a brisk walk has also been ples after a brisk walk has also been suggested in such patients. suggested in such patients.
Although Hummer
Although Hummer et al et al (1994 Hummer et al et al ( ) re-(1994 reported transient neutropenia in 22% of 68 ported transient neutropenia in 22% of 68 patients they defined leucopenia as a white patients they defined leucopenia as a white cell count cell count 5 53.5 3.5Â10 10 9 9 /l and neutropenia as a /l and neutropenia as a neutrophil count neutrophil count 5 52.0 2.0Â10 10 9 9 /l. The mean /l. The mean neutrophil count at the time of the transient neutrophil count at the time of the transient neutropenia was 1.78 neutropenia was 1.78Â10 10 9 9 /l. In the UK and /l. In the UK and generally, the cut-off points for leucopenia generally, the cut-off points for leucopenia and neutropenia used in clozapine monitorand neutropenia used in clozapine monitoring are lower (3.0 ing are lower (3.0Â10 10 9 9 /l and 1.5 /l and 1.5Â10 10 9 9 /l /l respectively) and patients with counts respectively) and patients with counts higher than this are not required to stop higher than this are not required to stop cloclozapine but are monitored more frequently. zapine but are monitored more frequently. The relevance of the findings of the study The relevance of the findings of the study to all clozapine-treated patients must thereto all clozapine-treated patients must therefore be considered with this point in mind. fore be considered with this point in mind.
The use of a hydrocortisone test to disThe use of a hydrocortisone test to distinguish between benign and malignant tinguish between benign and malignant neutropenia is of great interest but findings neutropenia is of great interest but findings must be interpreted with caution as the must be interpreted with caution as the study involved only three patients (Murry study involved only three patients (Murry & Laurent, 2001) . Furthermore, the risk & Laurent, 2001). Furthermore, the risk of further stressing a compromised bone of further stressing a compromised bone marrow must be borne in mind with such marrow must be borne in mind with such interventions. Whether it is possible to disinterventions. Whether it is possible to distinguish between transient neutropenia and tinguish between transient neutropenia and the prelude to agranulocytosis in clozapinethe prelude to agranulocytosis in clozapinetreated patients remains to be determined. treated patients remains to be determined.
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Hummer, M., Kurz, M., Barnas, C., Hummer, M., Kurz, M., Barnas, C., et al et al (1994 Barnas, C., et al et al ( ) (1994 Personality disorder and outcome Personality disorder and outcome in depression in depression
Newton-Howes Newton-Howes et al et al (2006) attempted to (2006) attempted to definitively answer the question of whether definitively answer the question of whether comorbid personality disorder affects outcomorbid personality disorder affects outcome in people with major depression. come in people with major depression. Their search strategy, study selection, data Their search strategy, study selection, data summary and analysis are clearly described. summary and analysis are clearly described.
1 8 6 1 8 6
B R I T I S H J O UR N A L O F P SYC HI AT RY B R I T I S H J O UR N A L O F P S YC H I AT RY
( 2 0 0 6 ) , 1 8 9, 1 8 6^1 However, the heterogeneous nature of their However, the heterogeneous nature of their data does not allow such definitive answers data does not allow such definitive answers as they claim. As has been noted previously as they claim. As has been noted previously (Charney (Charney et al et al, 1981; Black , 1981; Black et al et al, 1988; , 1988; Mulder, 2002) people with depression and Mulder, 2002) people with depression and comorbid personality disorders are less comorbid personality disorders are less likely to receive drugs or electroconvulsive likely to receive drugs or electroconvulsive therapy (ECT), precisely the treatments (as therapy (ECT), precisely the treatments (as this meta-analysis reports) that they are this meta-analysis reports) that they are more likely to respond to. Therefore, the more likely to respond to. Therefore, the only fair assessment of the effect of persononly fair assessment of the effect of personality disorders on outcome is the randomality disorders on outcome is the randomised controlled trial (RCT). When the ised controlled trial (RCT). When the meta-analysis was confined to such trials meta-analysis was confined to such trials the effect size was smaller but was still the effect size was smaller but was still significant. A recent meta-analysis that significant. A recent meta-analysis that restricted itself to RCTs of drug treatment restricted itself to RCTs of drug treatment reported no effect of recent comorbid reported no effect of recent comorbid personality disorder on outcome in people personality disorder on outcome in people with depression (Kool with depression (Kool et al et al, 2005) . This , 2005). This suggests that better studies with more effecsuggests that better studies with more effective treatments will report less effect of tive treatments will report less effect of comorbid personality disorder on outcome. comorbid personality disorder on outcome.
What does this mean clinically? Less What does this mean clinically? Less than the authors claim, I would suggest. than the authors claim, I would suggest. The sample size required to detect the The sample size required to detect the difference between the outcome of patients difference between the outcome of patients with depression and personality disorders with depression and personality disorders and similar patients but without personality and similar patients but without personality disorder exceeds 1000 (and this by using all disorder exceeds 1000 (and this by using all trials rather than just RCTs), suggesting trials rather than just RCTs), suggesting minimal effect in normal clinical practice. minimal effect in normal clinical practice. Although it seems like a good idea, there Although it seems like a good idea, there is no evidence that targeting comorbid is no evidence that targeting comorbid personality pathology is necessary and will personality pathology is necessary and will result in better outcomes for those with result in better outcomes for those with depression. The numbers needed to show depression. The numbers needed to show an effect of personality disorder on outan effect of personality disorder on outcome suggest that a treatment trial specificome suggest that a treatment trial specifically designed to look for a treatment cally designed to look for a treatment effect would require such large numbers effect would require such large numbers that it will never be performed. that it will never be performed.
What the meta-analysis suggests, along What the meta-analysis suggests, along with many recent studies, is that good treatwith many recent studies, is that good treatment of depression, particularly using drugs ment of depression, particularly using drugs and ECT if indicated, will result for the and ECT if indicated, will result for the most part in a similar outcome for people most part in a similar outcome for people with and without personality disorders. with and without personality disorders. Such treatments may in fact be effective Such treatments may in fact be effective for the comorbid personality disorder. for the comorbid personality disorder. Clinicians should be encouraged that Clinicians should be encouraged that aggressive treatment of mood disorder is aggressive treatment of mood disorder is likely to lead to a positive outcome in those likely to lead to a positive outcome in those with depression and comorbid personality with depression and comorbid personality disorder. disorder. Authors' reply: We did not set out to proWe did not set out to provide a definitive answer to a specific vide a definitive answer to a specific question; our objective was to provide a question; our objective was to provide a comprehensive synthesis of all available comprehensive synthesis of all available studies and, by using a systematic approach studies and, by using a systematic approach to data collection with limited exclusion to data collection with limited exclusion criteria and a robust statistical analysis, criteria and a robust statistical analysis, we have produced the best summary availwe have produced the best summary available to date. Although data from RCTs able to date. Although data from RCTs are valuable, they are not the sole arbiters are valuable, they are not the sole arbiters of association and so our information of association and so our information covers much more than the necessarily covers much more than the necessarily short-term span of an RCT. Even if we short-term span of an RCT. Even if we confine our analysis to the 14 RCTs in confine our analysis to the 14 RCTs in our review, we obtain an odds ratio of our review, we obtain an odds ratio of 1.60 (95% CI 1.25-2.06), indicating better 1.60 (95% CI 1.25-2.06), indicating better resolution of a depressive episode without resolution of a depressive episode without comorbid personality disorder. Both cohort comorbid personality disorder. Both cohort studies and case series support this finding, studies and case series support this finding, with all groups identifying a poorer outwith all groups identifying a poorer outcome in those with a personality disorder. come in those with a personality disorder.
The overview by Kool The overview by Kool et al et al (2005 Kool et al et al ( ) in-(2005 included just six RCTs, all of which involved cluded just six RCTs, all of which involved drug treatment with antidepressants and drug treatment with antidepressants and none of which extended beyond 24 weeks. none of which extended beyond 24 weeks. The judgement that these were the only The judgement that these were the only trials of 'high quality' may be suspect, as trials of 'high quality' may be suspect, as it is difficult to assess quality from pubit is difficult to assess quality from published papers (Soares lished papers (Soares et al et al, 2004) . In addi-, 2004). In addition, despite their claim that studies were tion, despite their claim that studies were excluded when 'they presented reanalyses excluded when 'they presented reanalyses of a study population that was already of a study population that was already included', we believe that their two largest included', we believe that their two largest studies (Hirschfeld studies (Hirschfeld et al et al, 1998; Russell , 1998; Russell et et al al, 2003) both stem from the same trial , 2003) both stem from the same trial (albeit with different outcomes) first (albeit with different outcomes) first reported by Rush reported by Rush et al et al (1998) . Excluding (1998). Excluding Russell Russell et al et al (2003) , from their meta- (2003), from their metaanalysis slightly widens the 95% CI for analysis slightly widens the 95% CI for the reported (inverted) odds ratio of 1.14 the reported (inverted) odds ratio of 1.14 from 0.93-1.39 to 0.88-1.45, neither of from 0.93-1.39 to 0.88-1.45, neither of which are inconsistent with our own which are inconsistent with our own estimate above. estimate above.
Our review also suggested that there Our review also suggested that there may be a better response to the treatment may be a better response to the treatment of comorbid depression and personality disof comorbid depression and personality disorder with antidepressant drugs than with order with antidepressant drugs than with other treatments, which is consistent with other treatments, which is consistent with Kool Kool et al et al (2005) . We remain optimistic (2005) . We remain optimistic about treating personality pathology about treating personality pathology successfully in this group, and think that successfully in this group, and think that newer treatments which focus on personalnewer treatments which focus on personality should be compared with aggressive ity should be compared with aggressive pharmacotherapy for those who are pharmacotherapy for those who are regarded as having 'resistant' depression. regarded as having 'resistant' depression. 
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Stillbirth^psychological impact Stillbirth^psychological impact on fathers on fathers
Although there is a lot of information on Although there is a lot of information on the psychological impact of stillbirth on the psychological impact of stillbirth on mothers, data on the effect on fathers is mothers, data on the effect on fathers is very rare. We often fail to acknowledge very rare. We often fail to acknowledge that fathers can have a difficult time after that fathers can have a difficult time after a stillbirth in separating their own grief a stillbirth in separating their own grief from that of the mother. Their role in from that of the mother. Their role in supporting the mother through this ordeal supporting the mother through this ordeal cannot be overemphasised and the recent cannot be overemphasised and the recent article by Turton article by Turton et al et al (2006) is important (2006) is important because it describes the psychological stress because it describes the psychological stress and needs of fathers during subsequent and needs of fathers during subsequent pregnancy and the puerperium. However, pregnancy and the puerperium. However, I would like to raise a few points which I would like to raise a few points which need further discussion. need further discussion.
Social support from family or partner Social support from family or partner following such a life event can have a subfollowing such a life event can have a substantial impact on subsequent mental and stantial impact on subsequent mental and physical well-being, which may also deterphysical well-being, which may also determine the subsequent level of coping. Turton mine the subsequent level of coping. Interestingly, the fact that fathers often Interestingly, the fact that fathers often refused to take part in the interview could refused to take part in the interview could have led to underestimation of the psychohave led to underestimation of the psychological impact of stillbirth and the underlogical impact of stillbirth and the underlying psychiatric morbidity. It would have lying psychiatric morbidity. It would have been informative if the authors had identibeen informative if the authors had identified the reasons for their refusal. This is fied the reasons for their refusal. This is particularly important since it is well particularly important since it is well accepted that fathers generally tend to accepted that fathers generally tend to minimise their problems, put on a 'brave minimise their problems, put on a 'brave face' and refuse to speak out. There is no face' and refuse to speak out. There is no mention of the reliability or validity of the mention of the reliability or validity of the scale used for the assessment of marital scale used for the assessment of marital satisfaction. Moreover, exclusion of Black satisfaction. Moreover, exclusion of Black participants and those from minority ethnic participants and those from minority ethnic groups limits the application of the results groups limits the application of the results to a wider general population. to a wider general population.
However, I think this is a relevant and However, I think this is a relevant and significant study which may prove to be significant study which may prove to be beneficial for a wider understanding of this beneficial for a wider understanding of this poorly recognised problem. It highlights the poorly recognised problem. It highlights the importance of actively encouraging fathers importance of actively encouraging fathers to be more forthcoming about their proto be more forthcoming about their problems and also helps health professionals blems and also helps health professionals to focus on high-risk couples. to focus on high-risk couples. We would like to expand on the points raised relating to sampling on the points raised relating to sampling and assessment tools. We accept the critiand assessment tools. We accept the criticism that relaxing the inclusion criteria cism that relaxing the inclusion criteria might have skewed the final results, might have skewed the final results, but have already explained our rationale but have already explained our rationale for this decision. Unfortunately it is not for this decision. Unfortunately it is not possible to make any inference about possible to make any inference about the psychological morbidity of nonthe psychological morbidity of nonparticipants. Non-responding fathers fell participants. Non-responding fathers fell into two groups: those who were persisinto two groups: those who were persistently unavailable and those who declined tently unavailable and those who declined to take part. Only one father gave a reason to take part. Only one father gave a reason for his refusal: rejection of what he perfor his refusal: rejection of what he perceived as a false assumption that it was ceived as a false assumption that it was possible for a parent to 'recover' from a possible for a parent to 'recover' from a stillbirth. Although we were active in seekstillbirth. Although we were active in seeking fathers' participation, ethical consideraing fathers' participation, ethical considerations did not permit us to persist in tions did not permit us to persist in questioning fathers who declined to take questioning fathers who declined to take part. Black couples and those from part. Black couples and those from minority ethnic groups were not excluded minority ethnic groups were not excluded from the study; rather they were from the study; rather they were under underrepresented as a result of higher represented as a result of higher nonnon-participation rates. participation rates. Two factors contributed to our use of a Two factors contributed to our use of a single dichotomous variable for the presingle dichotomous variable for the presence or absence of appropriate social sence or absence of appropriate social support. First, social support at the time support. First, social support at the time of loss was not a primary focus of the study of loss was not a primary focus of the study and we felt it appropriate to limit the numand we felt it appropriate to limit the number of questionnaires that participants had ber of questionnaires that participants had to complete. Second, research in this field to complete. Second, research in this field has relied on a range of assessment tools has relied on a range of assessment tools (e.g. Zeanah (e.g. Zeanah et al et al, 1995; Lin & Lasker, , 1995; Lin & Lasker, 1996) . The use of multiple complex tools 1996). The use of multiple complex tools limits the comparison of data across stulimits the comparison of data across studies. However, we accept the view that eladies. However, we accept the view that elaborating on the quality of support would borating on the quality of support would deepen the findings. The Golombok Rust deepen the findings. The Golombok Rust Inventory of Marital State, which was used Inventory of Marital State, which was used to assess marital satisfaction, is a short and to assess marital satisfaction, is a short and easy-to-administer assessment which has easy-to-administer assessment which has high face and content validity and good high face and content validity and good reliability (Rust reliability (Rust et al et al, 1988) . , 1988).
We hope that continuing research in We hope that continuing research in this field will lead to greater awareness of this field will lead to greater awareness of the needs of parents experiencing stillbirth. the needs of parents experiencing stillbirth. (2006) attacks the pharmaceutical industry for promoting the idea ceutical industry for promoting the idea that depression is 'caused by imbalances that depression is 'caused by imbalances in brain chemicals' and berates it for the in brain chemicals' and berates it for the fact that people are taking more prescripfact that people are taking more prescription drugs than ever before. She implies tion drugs than ever before. She implies that because the biochemical basis of that because the biochemical basis of depression is not known, the promotion depression is not known, the promotion of antidepressants is a plot to encourage of antidepressants is a plot to encourage profiteering. profiteering.
The history of medicine teaches us that The history of medicine teaches us that many crucial and life-saving drugs were many crucial and life-saving drugs were and still are used despite a lack of and still are used despite a lack of knowledge of their scientific action (e.g. knowledge of their scientific action (e.g. the use of steroids in asthma). In fact, there the use of steroids in asthma). In fact, there are very few instances where the scientific are very few instances where the scientific basis of action of crucial medicines is fully basis of action of crucial medicines is fully understood. The history of psychiatry understood. The history of psychiatry teaches us that before antidepressant mediteaches us that before antidepressant medication there was no treatment for deprescation there was no treatment for depression except waiting for natural recovery: sion except waiting for natural recovery: frequently a long and painful process durfrequently a long and painful process during which the patient often starved to death ing which the patient often starved to death or ended life by suicide. or ended life by suicide.
One can easily take, like Moncrieff, an One can easily take, like Moncrieff, an extreme view of the pharmaceutical indusextreme view of the pharmaceutical industry, emphasising how it controls research try, emphasising how it controls research and uses advertising to influence clinicians, and uses advertising to influence clinicians, and I note that the current issue of the and I note that the current issue of the Journal Journal has no fewer than 12 full-page has no fewer than 12 full-page colour advertisements promoting psychocolour advertisements promoting psychotropic medication. The alternative view, tropic medication. The alternative view, however, would be that the industry has however, would be that the industry has helped us to move out of the dark ages helped us to move out of the dark ages when all we could offer was asylum and when all we could offer was asylum and restraint. The reality is probably somerestraint. The reality is probably somewhere between these extremes. where between these extremes.
As a general psychiatrist with a special As a general psychiatrist with a special interest in psychological treatments (espeinterest in psychological treatments (especially cognitive-behavioural therapy) I am cially cognitive-behavioural therapy) I am not proposing that medication has all the not proposing that medication has all the answers or is even the preferred choice in answers or is even the preferred choice in all cases. However, I have to persuade all cases. However, I have to persuade many patients on a regular basis to take many patients on a regular basis to take antidepressant medication before improveantidepressant medication before improvement can occur. The 'chemical imbalance ment can occur. The 'chemical imbalance theory' is a useful working hypothesis for theory' is a useful working hypothesis for one cause for depression. There is a current one cause for depression. There is a current climate of opinion among those who reguclimate of opinion among those who regularly surf the internet that medication is larly surf the internet that medication is all bad, dangerous and addictive. Clinical all bad, dangerous and addictive. Clinical psychiatrists like me have an uphill battle psychiatrists like me have an uphill battle to persuade patients to take life-saving to persuade patients to take life-saving medication which articles such as those by medication which articles such as those by Moncrieff, and the websites she directs us Moncrieff, and the websites she directs us to, make even harder. to, make even harder.
Moncrieff, J. (2006) Moncrieff, J. (2006) Author's reply: By mentioning the use of By mentioning the use of steroids in asthma, Dr Stern highlights an steroids in asthma, Dr Stern highlights an important contrast between our underimportant contrast between our understanding of how drugs work in general standing of how drugs work in general medicine and how drugs work in psychimedicine and how drugs work in psychiatric conditions. In general medicine the atric conditions. In general medicine the effects of drugs can usually be understood effects of drugs can usually be understood by their actions on some level of the pathoby their actions on some level of the pathological process that generates the logical process that generates the symptoms. Thus, steroids reduce the symptoms. Thus, steroids reduce the inflammatory response that gives rise to inflammatory response that gives rise to some of the symptoms of asthma. In consome of the symptoms of asthma. In contrast there is no evidence that drugs used trast there is no evidence that drugs used in psychiatric conditions act on specific in psychiatric conditions act on specific neuropathological processes. No specific neuropathological processes. No specific physical pathology has been established physical pathology has been established for any major psychiatric condition and for any major psychiatric condition and other evidence that drugs might be specific other evidence that drugs might be specific is lacking. Instead I have suggested elseis lacking. Instead I have suggested elsewhere the alternative hypothesis that psywhere the alternative hypothesis that psychiatric drugs do not correct pathological chiatric drugs do not correct pathological brain states or chemical imbalances but brain states or chemical imbalances but create them (Moncrieff & Cohen, 2005 , create them (Moncrieff & Cohen, 2005 , 2006 . These drug-induced states might 2006). These drug-induced states might sometimes prove useful in psychiatric sometimes prove useful in psychiatric conditions, but the negative aspects of such conditions, but the negative aspects of such states are often likely to outweigh the states are often likely to outweigh the benefits that can be gained. However, drug benefits that can be gained. However, drug companies and the psychiatric profession companies and the psychiatric profession have presented psychiatric drugs as have presented psychiatric drugs as disease-specific treatments that correct disease-specific treatments that correct chemical imbalances. This view helps to chemical imbalances. This view helps to downplay the disadvantages of long-term downplay the disadvantages of long-term drug use and may help to create the context drug use and may help to create the context for the expansion of markets for psychiatric for the expansion of markets for psychiatric drugs. drugs.
As far as antidepressants are concerned, As far as antidepressants are concerned, there is little evidence that they have there is little evidence that they have specific antidepressant effects (Moncrieff specific antidepressant effects (Moncrieff & Cohen, 2006) or that they are 'life-& Cohen, 2006) or that they are 'lifesaving' in terms of reducing suicide saving' in terms of reducing suicide (Moncrieff & Kirsch, 2005) . There is no (Moncrieff & Kirsch, 2005) . There is no evidence that there is a chemical imbalance evidence that there is a chemical imbalance in people with depression, and I do not in people with depression, and I do not understand how we can be justified in perunderstand how we can be justified in persuading patients to see their problems in suading patients to see their problems in this way. Doing so runs the risk of underthis way. Doing so runs the risk of undermining patients' own coping mechanisms mining patients' own coping mechanisms and thereby increasing chronicity, depenand thereby increasing chronicity, dependence on services and use of prescribed dence on services and use of prescribed drugs. drugs.
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Initial rate of improvement Initial rate of improvement in major depression in major depression
Dr Mitchell (2006) suggests that it may be Dr Mitchell (2006) suggests that it may be pertinent to re-examine another commonly pertinent to re-examine another commonly quoted recommendation -that an antidequoted recommendation -that an antidepressant trial must be at least 6 to 8 weeks pressant trial must be at least 6 to 8 weeks before switching drugs. The evidence on before switching drugs. The evidence on which switch guidelines are based is weak which switch guidelines are based is weak but these guidelines are applied frequently but these guidelines are applied frequently in daily clinical practice. In previous studies in daily clinical practice. In previous studies symptom improvement at earlier time symptom improvement at earlier time points in relation to points in relation to response response has been inhas been investigated (e.g. Koran vestigated (e.g. Koran et al et al, 1995) but the , 1995) but the ultimate goal of depression treatment is ultimate goal of depression treatment is complete complete remission remission. Remission takes longer . Remission takes longer than 4-6 weeks to achieve but substantial than 4-6 weeks to achieve but substantial improvement is unlikely after 10-12 weeks improvement is unlikely after 10-12 weeks 
investigated the relationship between initial investigated the relationship between initial change in symptoms and remission by week change in symptoms and remission by week 12 and demonstrated that even when there 12 and demonstrated that even when there was no improvement after 6 weeks of treatwas no improvement after 6 weeks of treatment, an antidepressant trial should be ment, an antidepressant trial should be continued because the proportion of continued because the proportion of patients attaining remission by week 12 patients attaining remission by week 12 was still considerable (i.e. greater than was still considerable (i.e. greater than 30%). They argued that a switch of anti-30%). They argued that a switch of antidepressant medication would be unlikely depressant medication would be unlikely to have resulted in higher remission rates. to have resulted in higher remission rates. Furthermore, large studies are required in Furthermore, large studies are required in which change in symptoms is frequently which change in symptoms is frequently measured at uniform time-points and dimeasured at uniform time-points and dimensions other than those measured by mensions other than those measured by conventional questionnaires for depression conventional questionnaires for depression are assessed. These might be more sensitive are assessed. These might be more sensitive to early change following the initiation of to early change following the initiation of antidepressant treatment (Harmer antidepressant treatment (Harmer et al et al, , 2004) , and therefore might better predict 2004), and therefore might better predict which patients will attain remission. Calcuwhich patients will attain remission. Calculation of the sensitivity, specificity, area lation of the sensitivity, specificity, area under the receiver operating characteristic under the receiver operating characteristic curve, and positive and negative predictive curve, and positive and negative predictive power to assess the likelihood of remission power to assess the likelihood of remission for various levels of symptom change at diffor various levels of symptom change at different time-points would help clinicians to ferent time-points would help clinicians to decide on clinical applicability. Results decide on clinical applicability. Results from such studies will improve the evidence from such studies will improve the evidence on which switch guidelines are based. on which switch guidelines are based. 
depression has been poor but it is depression has been poor but it is (slowly) improving (DeBattista, 2006) . Dr (slowly) improving (DeBattista, 2006) . Dr Vergouwen's suggestion that predictors of Vergouwen's suggestion that predictors of remission should be sought scientifically remission should be sought scientifically is most welcome. The studies mentioned is most welcome. The studies mentioned are some of a number that look at the are some of a number that look at the proportion of patients who respond late proportion of patients who respond late when early antidepressant response is when early antidepressant response is disappointing (e.g. Mulsant disappointing (e.g. Mulsant et al et al, 2006) . , 2006). I am sure it will not be long before I am sure it will not be long before someone performs a meta-analysis yieldsomeone performs a meta-analysis yielding more-conclusive results. However, in ing more-conclusive results. However, in clinical practice the alternative to conticlinical practice the alternative to continuing a drug which has generated a poor nuing a drug which has generated a poor response is most commonly switching to response is most commonly switching to another. However, from an evidence base another. However, from an evidence base standpoint this is where things get standpoint this is where things get complex. complex.
When considering analysis of benefit When considering analysis of benefit from a switch strategy after a certain numfrom a switch strategy after a certain number of weeks (say an 8-week ber of weeks (say an 8-week v v. 4-week . 4-week switch with follow-up at 24 weeks), the switch with follow-up at 24 weeks), the methodology of an ideal trial is not methodology of an ideal trial is not straightforward and hence rare (to the straightforward and hence rare (to the point of invisibility!) in the literature. Three point of invisibility!) in the literature. Three arms are required. Arm 1 includes patients arms are required. Arm 1 includes patients who switch if non-responsive at 4 weeks; who switch if non-responsive at 4 weeks; arm 2 those who switch if non-responsive arm 2 those who switch if non-responsive at 8 weeks and, equally importantly, arm at 8 weeks and, equally importantly, arm 3 patients who do not switch and stay on 3 patients who do not switch and stay on their original antidepressant for the duratheir original antidepressant for the duration of the trial. The third arm establishes tion of the trial. The third arm establishes how many would continue to enter rehow many would continue to enter remission even if initially non-responsive. mission even if initially non-responsive. Comparing switch with maximisation or Comparing switch with maximisation or augmentation or combination strategies augmentation or combination strategies would also ideally require a study of similar would also ideally require a study of similar design. I know of no such studies, and the design. I know of no such studies, and the recruitment of the necessary number of recruitment of the necessary number of patients with some level of treatment resispatients with some level of treatment resistance is very difficult. A recent review of tance is very difficult. A recent review of combination trials for treatment-resistant combination trials for treatment-resistant depression found only two that were depression found only two that were randomised against a drug plus placebo randomised against a drug plus placebo arm (Dodd arm (Dodd et al et al, 2005) . , 2005). The other important issue is exactly The other important issue is exactly how to separate responders from nonhow to separate responders from nonresponders (or remitters from nonresponders (or remitters from nonremitters) (Israel, 2006) . In my view, remitters) (Israel, 2006) . In my view, because any definition of response is because any definition of response is arbitrary, the threshold taken to define arbitrary, the threshold taken to define response (20%, 30% or 50% improveresponse (20%, 30% or 50% improvement, for example) will affect the success ment, for example) will affect the success of the switch strategy. The main danger of of the switch strategy. The main danger of switching too early is robbing a patient switching too early is robbing a patient who was on a trajectory of good improvewho was on a trajectory of good improvement from continuing successful treatment. ment from continuing successful treatment. The danger of switching too late is leaving The danger of switching too late is leaving a patient with distressing symptoms a patient with distressing symptoms longer than necessary without effective longer than necessary without effective treatment. In reality, ratings on a deprestreatment. In reality, ratings on a depression scale at 4 or 8 weeks after starting sion scale at 4 or 8 weeks after starting treatment will be somewhere between basetreatment will be somewhere between baseline and entirely asymptomatic -thus line and entirely asymptomatic -thus virtually all patients could be considered virtually all patients could be considered 'partial responders'. Many areas of psycho-'partial responders'. Many areas of psychopharmacology are moving towards early pharmacology are moving towards early identification and treatment. I doubt that identification and treatment. I doubt that treatment-resistant depression will be the treatment-resistant depression will be the exception. exception.
Obsessive^compulsive disorder Obsessive^compulsive disorder and central nervous system and central nervous system autoimmunity autoimmunity Dale Dale et al et al (2005) found high levels of anti-(2005) found high levels of antibasal ganglia antibodies (ABGA) in the sera basal ganglia antibodies (ABGA) in the sera of children with obsessive-compulsive disof children with obsessive-compulsive disorder (OCD) compared with control order (OCD) compared with control groups of children with streptococcal infecgroups of children with streptococcal infection without OCD, paediatric autoimmune tion without OCD, paediatric autoimmune disease and neurological disorders (stroke, disease and neurological disorders (stroke, movement disorders and encephalitis) and movement disorders and encephalitis) and concluded that central nervous system concluded that central nervous system autoimmunity may play a role in a autoimmunity may play a role in a significant subgroup of children with OCD. significant subgroup of children with OCD.
Recently, we found another autoRecently, we found another autoantibody, anti-phosphatidylethanolamine antibody, anti-phosphatidylethanolamine (aPE), which may have been associated (aPE), which may have been associated with the sudden onset of OCD in a with the sudden onset of OCD in a 5-year-old girl. Six weeks prior to showing 5-year-old girl. Six weeks prior to showing symptoms of OCD, the girl was diagnosed symptoms of OCD, the girl was diagnosed with an ear infection, for which she with an ear infection, for which she received a full course of antibiotics. She received a full course of antibiotics. She presented at our clinic 2 months after the presented at our clinic 2 months after the onset of OCD symptoms. Past medical onset of OCD symptoms. Past medical history was significant for recurrent ear history was significant for recurrent ear infection. Physical and neurological infection. Physical and neurological examinations were normal; no tics were examinations were normal; no tics were observed. There was no family history of observed. There was no family history of OCD. OCD.
At the index visit, the patient was negaAt the index visit, the patient was negative for streptolysin O antibody. To investigate an autoimmune diaTo investigate an autoimmune diathesis, the patient was tested for IgG, IgA thesis, the patient was tested for IgG, IgA and aPE, anti-phosphatidylserine, antiand aPE, anti-phosphatidylserine, antiphosphatidylcholine and anti-cardiolipin phosphatidylcholine and anti-cardiolipin antibodies (Sokol antibodies (Sokol et al et al, 2000) . Serial anti-, 2000) . Serial antiphospholipid antibody testing revealed the phospholipid antibody testing revealed the persistence of IgG aPE antibodies; aPE antipersistence of IgG aPE antibodies; aPE antibody levels were coincident with the body levels were coincident with the expression of OCD symptoms. The index expression of OCD symptoms. The index and day 113 sera were also positive for and day 113 sera were also positive for IgG anti-phosphatidylserine antibodies. IgG anti-phosphatidylserine antibodies. The patient was begun on a low dose of The patient was begun on a low dose of sertraline and her OCD improved. sertraline and her OCD improved.
We believe that this patient has a We believe that this patient has a 'paediatric autoimmune neuropsychiatric 'paediatric autoimmune neuropsychiatric disorder associated with streptococcal indisorder associated with streptococcal infection' (PANDAS-like condition) because fection' (PANDAS-like condition) because the criteria, except for evidence of a group the criteria, except for evidence of a group A streptococcal infection, were met. She A streptococcal infection, were met. She had a history of repeated ear infections had a history of repeated ear infections but her OCD symptoms occurred after the but her OCD symptoms occurred after the most recent infection. Without documentmost recent infection. Without documenting the infectious agent, the elevated levels ing the infectious agent, the elevated levels of aPE antibody suggest that she mounted of aPE antibody suggest that she mounted an autoimmune reaction following another an autoimmune reaction following another ear infection which led to the development ear infection which led to the development of OCD. of OCD.
We have found aPE antibodies in other We have found aPE antibodies in other neuropsychiatric conditions. An adolescent neuropsychiatric conditions. An adolescent girl with a basal ganglia stroke had IgA girl with a basal ganglia stroke had IgA aPE antibodies in her serum and IgG and aPE antibodies in her serum and IgG and IgA aPE antibodies in her cerebrospinal IgA aPE antibodies in her cerebrospinal fluid; she experienced seizures and depresfluid; she experienced seizures and depression subsequent to the stroke (Sokol sion subsequent to the stroke (Sokol et al et al, , 2000) . Furthermore, aPE was the most 2000). Furthermore, aPE was the most frequently detected anti-phospholipid frequently detected anti-phospholipid antibody in the serum of patients with antibody in the serum of patients with psychosis (O'Brien psychosis (O'Brien et al et al, 2004) . One-third , 2004) . One-third of cerebrospinal fluid samples from this of cerebrospinal fluid samples from this group contained IgG aPE antibody in group contained IgG aPE antibody in the absence of this antibody in serum, the absence of this antibody in serum, suggesting intrathecal synthesis. We prosuggesting intrathecal synthesis. We propose that aPE antibody may attack the pose that aPE antibody may attack the basal ganglia, leading to its association basal ganglia, leading to its association with OCD and other disorders of the with OCD and other disorders of the brain. brain.
Although we report the finding of aPE Although we report the finding of aPE antibodies with OCD in a single patient, antibodies with OCD in a single patient, we believe that aPE antibody should be we believe that aPE antibody should be considered as an additional autoimmune considered as an additional autoimmune marker in post-infectious OCD. marker in post-infectious OCD. (ethyl-EPA) to be effective in the treatment of bipolar depreseffective in the treatment of bipolar depression. However, no mention is made of the sion. However, no mention is made of the dietary intake of ethyl-EPA among the randietary intake of ethyl-EPA among the randomised groups. Ethyl-EPA is a naturally domised groups. Ethyl-EPA is a naturally occurring substance and hence a potential occurring substance and hence a potential confounding variable. The statistically sigconfounding variable. The statistically significant improvements in the ethyl-EPA nificant improvements in the ethyl-EPA group(s) compared with placebo in terms group(s) compared with placebo in terms of decreases in scores on the Hamilton of decreases in scores on the Hamilton Rating Scale for Depression and the Rating Scale for Depression and the Clinical Global Impression Scale could Clinical Global Impression Scale could simply have been a result of differences simply have been a result of differences in dietary ethyl-EPA intake. Such a differin dietary ethyl-EPA intake. Such a difference is likely to have involved increased ence is likely to have involved increased intake in the ethyl-EPA group(s), but intake in the ethyl-EPA group(s), but decreased intake in these groups could have decreased intake in these groups could have lessened any potential improvements. lessened any potential improvements. Further studies of omega-3 fatty acids Further studies of omega-3 fatty acids must control for the potential confoundmust control for the potential confounding independent variable of dietary ing independent variable of dietary intake. intake. One hundred years ago One hundred years ago
